Table 4 Mutational profiles

From: Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile

Cases

Mutations

CNAa loss

CNAa gain

Amplifications

TC1

CBL, RASA1

Chromosome 9

Chromosome 17

 

TC2

KMT2C b , ERBB2, ERCC2, TET2, MED12, MTOR, TRAF2, DAXX

Chromosome 9

Chromosome 17

MDM2 (12q14.3-q15)b

CDK4 (12q14)b

TC3

PMS2b, RAD21b, STAT5A,

NOTCH2, PLK2

Chromosome 9

Chromosome 17

 

TC4

KMT2C b

Chromosome 9

Chromosome 17

 

TC5

KDM5C b , TP53 b

Chromosome 9

Chromosome 17

 

TC6

Not detected

Chromosome 9

Chromosome 17

 

TC7

Not detected

Chromosome 9

Chromosome 17

 

TC8

NOTCH3

Chromosome 9

Chromosome 17

 

TC9

KDM5C b , FBXW7 b , KEAP1 b , DNMT3A, ERBB2

Chromosome 9

Chromosome 17

 
  1. aCopy number alterations
  2. bKnown or likely oncogenic alterations